Related references
Note: Only part of the references are listed.A urine extracellular vesicle circRNA classifier for detection of high-grade prostate cancer in patients with prostate-specific antigen 2-10 ng/mL at initial biopsy
Ya-Di He et al.
MOLECULAR CANCER (2021)
Pharmacokinetics, Safety, and Antitumor Effect of Apalutamide with Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer: Phase Ib Study
Edwin M. Posadas et al.
CLINICAL CANCER RESEARCH (2020)
Extracellular Vesicles Long RNA Sequencing Reveals Abundant mRNA, circRNA, and lncRNA in Human Blood as Potential Biomarkers for Cancer Diagnosis
Yuchen Li et al.
CLINICAL CHEMISTRY (2019)
Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study
Andrew J. Armstrong et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Circular RNAs add diversity to androgen receptor isoform repertoire in castration-resistant prostate cancer
Subing Cao et al.
ONCOGENE (2019)
Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
Adam Sharp et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Detection of CTC Clusters and a Dedifferentiated RNA-Expression Survival Signature in Prostate Cancer
Molly Kozminsky et al.
ADVANCED SCIENCE (2019)
Preclinical study using circular RNA 17 and micro RNA 181c-5p to suppress the enzalutamide-resistant prostate cancer progression
Gang Wu et al.
CELL DEATH & DISEASE (2019)
Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression
Yajia Zhang et al.
NATURE GENETICS (2018)
Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma
A. K. Krug et al.
ANNALS OF ONCOLOGY (2018)
Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9® to Suppress Enzalutamide-resistant Prostate Cancer Progression
Ronghao Wang et al.
EUROPEAN UROLOGY (2017)
Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns
Bram De laere et al.
EUROPEAN UROLOGY (2017)
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients
Marzia Del Re et al.
EUROPEAN UROLOGY (2017)
Prospective Study of CRMP4 Promoter Methylation in Prostate Biopsies as a Predictor For Lymph Node Metastases
Xin Gao et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Prospective Study of CRMP4 Promoter Methylation in Prostate Biopsies as a Predictor For Lymph Node Metastases
Xin Gao et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Circular RNA ciRS-7-A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer
Wenhao Weng et al.
CLINICAL CANCER RESEARCH (2017)
Oncogenic Role of Fusion-circRNAs Derived from Cancer-Associated Chromosomal Translocations
Jlenia Guarnerio et al.
CELL (2016)
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
Karel G. M. Moons et al.
ANNALS OF INTERNAL MEDICINE (2015)
The RNA Binding Protein Quaking Regulates Formation of circRNAs
Simon J. Conn et al.
CELL (2015)
Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis
Yan Li et al.
CELL RESEARCH (2015)
Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
Xiaoyi Huang et al.
EUROPEAN UROLOGY (2015)
Do Circulating Tumor Cells, Exosomes, and Circulating Tumor Nucleic Acids Have Clinical Utility? A Report of the Association for Molecular Pathology
Bert Gold et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
Plasma AR and abiraterone-resistant prostate cancer
Alessandro Romanel et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer
Susan Halabi et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
circBase: a database for circular RNAs
Petar Glazar et al.
RNA (2014)
lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs
Liuqing Yang et al.
NATURE (2013)
Natural RNA circles function as efficient microRNA sponges
Thomas B. Hansen et al.
NATURE (2013)
Absolute quantification by droplet digital PCR versus analog real-time PCR
Christopher M. Hindson et al.
NATURE METHODS (2013)
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study
David Olmos et al.
LANCET ONCOLOGY (2012)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: Recommendations of the prostate cancer clinical trials working group
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven
Gerhardt Attard et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Hormonal impact of the 17α-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer
A O'Donnell et al.
BRITISH JOURNAL OF CANCER (2004)
Share Paper
